國家衛生研究院 NHRI:Item 3990099045/7185
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12500/13673 (91%)
造訪人次 : 2478202      線上人數 : 85
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7185


    題名: Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines
    作者: Chen, HW;Chen, HY;Wang, LT;Wang, FH;Fang, LW;Lai, HY;Chen, HH;Lu, J;Hung, MS;Cheng, Y;Chen, MY;Liu, SJ;Chong, P;Lee, OK;Hsu, SC
    貢獻者: Division of Vaccine Research and Development;Division of Infectious Diseases;Institute of Biotechnology and Pharmaceutical Research
    摘要: Mesenchymal stem/stromal cells (MSCs) are promising potential candidates for the treatment of immunological diseases because of their immunosuppressive functions. However, the molecular mechanisms that mediate MSCs' immunosuppressive activity remain elusive. In this article, we report for the first time, to our knowledge, that secreted growth-regulated oncogene (GRO) chemokines, specifically GRO-gamma, in human MSC-conditioned media have an effect on the differentiation and the function of human monocyte-derived dendritic cells. The monocyte-derived dendritic cells were driven toward a myeloid-derived suppressor cell (MDSC)-like phenotype by the GRO chemokines. GRO-gamma-treated MDSCs had a tolerogenic phenotype that was characterized by an increase in the secretion of IL-10 and IL-4, and a reduction in the production of IL-12 and IFN-gamma. We have also shown that the mRNA expression levels of the arginase-1 and inducible NO synthase genes, which characterize MDSCs, were upregulated by GRO-gamma-primed mouse bone marrow cells. In addition, the ability of GRO-gamma-treated bone marrow-derived dendritic cells to stimulate the OVA-specific CD8+ T (OT-1) cell proliferation and the cytokine production of IFN-gamma and TNF-alpha were significantly decreased in vivo. Our findings allow a greater understanding of how MDSCs can be generated and offer new perspectives to exploit the potential of MDSCs for alternative approaches to treat chronic inflammation and autoimmunity, as well as for the prevention of transplant rejection.
    日期: 2013-05
    關聯: Journal of Immunology. 2013 May;190(10):5065-5077.
    Link to: http://dx.doi.org/10.4049/jimmunol.1202775
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0022-1767&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000318546700018
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84877836310
    顯示於類別:[許素菁] 期刊論文
    [莊再成] 期刊論文
    [劉士任] 期刊論文
    [陳信偉] 期刊論文
    [洪明秀] 期刊論文
    [張堯] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB23589610.pdf1682KbAdobe PDF834檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋